Went Gregory T 4
4 · Adamas Pharmaceuticals Inc · Filed Mar 9, 2018
Insider Transaction Report
Form 4
Went Gregory T
DirectorChief Executive Officer10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2018-03-06+123,750→ 123,750 totalExercise: $25.66Exp: 2028-03-05→ Common Stock (123,750 underlying) - Award
Common Stock
2018-03-06+20,625→ 187,151 total
Holdings
- 195,392(indirect: By Trust)
Common Stock
- 80,000(indirect: By Trust)
Common Stock
- 80,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest as follows: 25% of the total number of Restricted Stock Units will vest on each of March 20, 2019, March 20, 2020, March 20, 2021 and March 20, 2022, subject to Reporting Person's Continuous Service as of each such date.
- [F2]The Option shares shall vest as follows: 1/48th of the option shares shall vest on the 1st of each month beginning with April 1, 2018, subject to Reporting Person's Continuous Service as of each such date.